Kee Song Bio-Technology Holdings (ROCO:1258) Interest Expense : NT$-26 Mil (TTM As of Mar. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Kee Song Bio-Technology Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Kee Song Bio-Technology Holdings's interest expense for the three months ended in Mar. 2023 was NT$ -7 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2023 was NT$-26 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Kee Song Bio-Technology Holdings's Operating Income for the three months ended in Mar. 2023 was NT$ 69 Mil. Kee Song Bio-Technology Holdings's Interest Expense for the three months ended in Mar. 2023 was NT$ -7 Mil. Kee Song Bio-Technology Holdings's Interest Coverage for the quarter that ended in Mar. 2023 was 10.23. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Kee Song Bio-Technology Holdings Interest Expense Historical Data

The historical data trend for Kee Song Bio-Technology Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kee Song Bio-Technology Holdings Interest Expense Chart

Kee Song Bio-Technology Holdings Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-41.11

-54.83

-47.61

-38.87

-26.11

Kee Song Bio-Technology Holdings Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Interest Expense	Get a 7-Day Free Trial															-6.64	-6.55	-6.27	-6.65	-6.72

Kee Song Bio-Technology Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-26 Mil.

Kee Song Bio-Technology Holdings (ROCO:1258) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Kee Song Bio-Technology Holdings's Interest Expense for the three months ended in Mar. 2023 was NT$-7 Mil. Its Operating Income for the three months ended in Mar. 2023 was NT$69 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2023 was NT$866 Mil.

Kee Song Bio-Technology Holdings's Interest Coverage for the quarter that ended in Mar. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2023 )	/	Interest Expense (Q: Mar. 2023 )
	=	-1	*	68.778	/	-6.72
	=	10.23

The higher the ratio, the stronger the company's financial strength is.

Kee Song Bio-Technology Holdings (ROCO:1258) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kee Song Bio-Technology Holdings Ltd (ROCO:1258) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Songjiang Road, 104, 8th Floor, No. 51, Zhongshan District, Taipei, TWN, 104

Website

https://www.keesongbiotech.com

Kee Song Bio-Technology Holdings Ltd is engaged in the processing and distribution of meat products. This includes poultry, production, and sale of chicken as well as the trade of frozen meat and prepared food. It has two reportable segments; the Poultry and processing distribution segment which is engaged in the business of importing, slaughtering, wholesaling, and retailing poultry and consumable goods of all kinds; and the Poultry farming segment involved in the business of poultry farming. It derives a majority of its revenue from the poultry farming segment.

Kee Song Bio-Technology Holdings (ROCO:1258) Headlines

No Headlines